April 9, 2021
Via: Contract PharmaBora Pharmaceutical Laboratories, a division of Bora Pharmaceuticals, has added roller compaction technology to its solid dose capability offerings at its Zhunan, Taiwan contract manufacturing and packaging facility. The Zhunan facility manufacturers complex oral solid dose (OSD) formulations with expertise […]
April 6, 2021
Via: CNBCPresident Joe Biden announced Tuesday that states should open Covid-19 vaccine appointments to all U.S. adults by April 19, moving up his original deadline by nearly two weeks. Biden announced the new deadline after he visited a vaccination site in […]
Biotech, Cell and Gene Therapy, Industry
April 6, 2021
Via: BioSpaceShanghai Stock Exchange listed biotech company HitGen Inc. (“HitGen”) announced important research progress in a collaboration with BioAge Labs, Inc. (“BioAge”), a private biotechnology company developing targeted small molecules for the treatment of diseases of aging. The companies have conducted […]
Biotech, FDA, Industry, Regulations
April 5, 2021
Via: BioSpaceTetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX:TBP)(OTCQB:TBPMF)(FRA:JAM1), a biopharmaceutical pioneer in immunomodulator drug discovery and development is pleased to announce that the U.S. Food and Drug Administration (FDA) has favorably reviewed the preclinical data package and clinical development plan […]
Biotech, Industry, Manufacturing, News, Research and Development, Vaccines
April 5, 2021
Via: BioSpaceEmergent BioSolutions Inc. (NYSE:EBS) today announced that the Company continues to be on track with its manufacturing agreements related to COVID-19 vaccines and confirmed that there are no changes to its financial guidance for 2021. In addition, the Company received […]
April 2, 2021
Via: BioSpaceCOVID-19 is a pneumonic disease that is caused by SARS-Cov2 virus. Previous ancestors of COVID-19 virus are SARS-CoV and MERS Virus. Loss of few base pairs has led to the mutation in the genetic material of SARS-CoV2. High multiplication rate […]
April 1, 2021
Via: Biopharma DiveThe FDA’s emergency authorization of J&J’s vaccine late last month boosted the quickening rollout of vaccines in the U.S., adding a third option in addition to shots from Pfizer and Moderna. Yet, previous delays in manufacturing meant J&J only had […]
Cell and Gene Therapy, FDA, Industry, Regulations
April 1, 2021
Via: EPM MagazineIn January 2020, the US Food and Drug Administration (FDA) published a series of seven guidances regarding cell and gene therapy. These have not come too soon, given some much-publicised regulatory rejections. For example, the FDA turning down the Biologics […]
March 31, 2021
Via: Biopharma DiveAmgen has recently stepped up its dealmaking activity as it tries to bolster its pipeline of treatments for cancer and inflammation. Earlier this month, the California biotech announced plans to pay $1.9 billion for Five Prime Therapeutics, which is focused […]
Industry, Manufacturing, Research and Development, Vaccines
March 29, 2021
Via: World Pharma NewsEMA’s human medicines committee (CHMP) has adopted several important recommendations that will increase manufacturing capacity and supply of COVID-19 vaccines in the EU. New manufacturing site for AstraZeneca’s COVID-19 vaccine A new manufacturing site has been approved for the production […]
Cell and Gene Therapy, Industry
March 29, 2021
Via: Genetic Engineering and Biotechnology NewsThe innate immune system scans for signs—such as misplaced genetic material—that a pathogen or dangerous mutation could cause disease. When DNA is found in areas of the cell other than the nucleus, which can occur due to viruses or cancer, […]
March 25, 2021
Via: BioSpaceSeveral new initial public offering (IPO) announcements have been made by international and U.S.-based biopharmaceutical and biotechnology companies in the past couple of days, with Dutch biotechnology company LAVA Therapeutics leading the pact. LAVA, a company harnessing expertise in bispecific […]
Copyright © 2021. All rights reserved
